Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04360941
Title PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer (PAveMenT)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Royal Marsden NHS Foundation Trust
Age Groups: senior | adult
Covered Countries

No variant requirements are available.